PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1218793
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1218793
According to Stratistics MRC, the Global ENT Laser Devices Market is accounted for $127.75 million in 2022 and is expected to reach $211.09 million by 2028 growing at a CAGR of 8.73% during the forecast period. The term "ENT lasers" is also frequently used to refer to CO2 lasers. In Otolaryngology, CO2 laser surgery is frequently used to treat conditions of the ear, nose, and throat. It is a minimally invasive surgery (MIS) that is completed quickly, with few side effects, and with absolute precision. By having pacemakers in their hearts, the elderly can put it into action. Particularly in the healthcare industry, laser technology has become increasingly popular on a global scale. Laser surgery has many benefits, some of which are minimal invasion, minimal bleeding, and atraumatic experience. These devices also have the important advantage of reducing the amount of time needed for surgery. The use of ENT laser equipment has increased as a result of technological developments in ENT surgery. Blood transfusions are no longer necessary because new laser device types have reduced blood loss. These important factors have led to a rise in the use of laser equipment during ENT procedures, which will ultimately fuel market expansion.
According to estimates published by QualSight, the number of LASIK vision correction procedures in the US through 2019 reached 23 million, with myopia surgeries comprising the bulk of all surgeries.
Market Dynamics:
Driver:
The increasing prevalence of ENT disorders
The ear, nose, and throat, among other important body parts affected by ENT disorders, are crucial for maintaining the body's sense of balance in addition to serving as sensory organs. Hospitalizations for ENT conditions like sinusitis, tonsillitis, sleep apnea, and throat and mouth cancer have increased as a result of the development of new surgical techniques. In addition, the increasing frequency of inflammatory disorders of the ear, nose, and throat shows the need for cutting-edge treatment methods and devices. Due to this demand, a growing number of vendors are concentrating on extending their selection of ENT laser devices, which can spur market expansion.
Restraint:
High cost for ENT surgeries
The primary factor severely impeding the expansion of this market is the higher cost of ENT procedures. An ENT procedure can cost up to USD 10,000 in total. People in developing nations might not be able to afford such expensive related services. These factors may limit the growth during the forecast period by impeding the widespread adoption of ENT laser devices.
Opportunity:
Rapid technological improvements
ENT laser devices are now being used more frequently as a result of technological developments in ENT surgery. Blood transfusions are no longer necessary because new laser device types have reduced blood loss. Cosmetic ENT surgeries are now performed frequently all over the world and are predicted to grow significantly. These important factors have led to a rise in the use of laser equipment during ENT procedures, which will ultimately fuel market expansion.
Threat:
Stringent regulations
Regulations differ from region to region because it's crucial to follow several rules and guidelines related to the security of laser products. Furthermore, the high cost of ENT procedures, product recalls, and strict laws and regulations governing the production and use of laser devices could restrain market expansion during the forecast period.
COVID-19 Impact
A unforeseen COVID-19 outbreak that resulted in significant market damage and widespread illness and death. Additionally, due to the pandemic, many ENT clinics have closed and elective surgical procedures (ESPs) have been discontinued, which has hurt the sale of ENT medical devices. Additionally, there were restrictions on the import and export of raw materials and other finished goods from other nations, such as China. These restrictions led to a supply-demand imbalance in early 2020, which is what caused the regional market for ENT laser devices to slow down. However, lockdowns have been lifted and raw material import and export have resumed as a result of the declining number of COVID-19 cases.
The Throat and Mouth Cancer segment is expected to be the largest during the forecast period
The Throat and Mouth Cancer segment is anticipated to witness largest share during the projection period. Throat and mouth cancer dominated the market because it is becoming more and more common in the world. About 54,010 adult patients (38,800 men and 15,210 women) were found to have oral and oropharyngeal cancer in the United States this year. This increase in cancer cases fuels market expansion.
The Ambulatory Surgical Centers segment is expected to have the highest CAGR during the forecast period
The market's popularity of ambulatory surgical centres has grown due to the demand for ENT procedures therefore Ambulatory Surgical Centers segment is anticipated to register highest CAGR over the forecast period. Demand is being driven by the accessibility of health infrastructure, the affordability of ENT procedures, and growing public awareness of the success or failure of procedures. ASCs strive to give patients the best surgical experience while charging the government, other parties, and patients the least amount of money.
Region with largest share:
Due to the rising number of ear, nose, and throat cancer cases each year, North America region is expected to hold largest share during the forecast period. The North America region accounts for nearly 43% of the market's overall growth. Additionally, according to the American Cancer Society, there will be nearly 12,960 new cases of laryngeal cancer in the country in 2021, contributing to about 3770 fatalities. Such occurrences fuel market expansion in the region.
Region with highest CAGR:
During the forecast period, the market in Asia Pacific is anticipated to have the highest CAGR. The Asian ENT devices market is anticipated to grow as a result of factors including a rising preference for minimally invasive ENT procedures, rising disposable income in developing nations, a rapidly increasing elderly population, increased focus on India by market players, and laxer regulatory standards.
Key players in the market
Some of the key players profiled in the ENT Laser Devices Market include IRIDEX Corp., Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Smith and Nephew plc, Sunny Optoelectronic Technology Co. Ltd, Limmer Laser GmbH, Lumenis Ltd., Olympus Corp., XIO Group, ARC Laser GmbH., Boston Scientific Corp. and El.En. S.p.a.
Key Developments:
In September 2021, Boston Scientific Corp, Closes the Acquisition of Lumenis LTD. Surgical Business from Baring Private Equity Asia. The Lumenis surgical business inculcates fibres and accessories and premier laser systems implemented for otolaryngology, and urology procedures, with total revenue expected to be around $200 million for 2021.
In July 2020, Olympus Corp launched SOLTIVE Super Pulsed Laser systems to deliver exceptional performance in a small and versatile package. Its 150u fibre can provide approximately three times the total power of competitor's small fibers4.
Types Covered:
Portability Covered:
Applications Covered:
End Users Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options: